- On November 3, 2022, Amphastar's ( NASDAQ: AMPH ) board authorized a $50 million increase to the company's share buyback program, which is expected to continue for an indefinite period of time.
- The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, and other conditions.
- Shares are down 9.7% after-hours .
- Earlier, Amphastar Pharmaceuticals Non-GAAP EPS of $0.38 misses by $0.01, revenue of $120.13M misses by $6.27M .
For further details see:
Amphastar authorizes $50M buyback